Mark E. Dmytruk - 10 Mar 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-fact
Issuer symbol
DNA
Transactions as of
10 Mar 2022
Net transactions value
-$976,956
Form type
4
Filing time
14 Mar 2022, 21:33:15 UTC
Previous filing
26 Jan 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Class B Common Stock Award $0 +2,617,558 +833% $0.000000 2,931,655 10 Mar 2022 Class A Common Stock 2,617,558 Direct F1, F2
transaction DNA Class B Common Stock Tax liability $976,956 -289,898 -9.9% $3.37 2,641,757 10 Mar 2022 Class A Common Stock 289,898 Direct F1, F2, F3
transaction DNA Class B Common Stock Award $0 +500,000 +19% $0.000000 3,181,757 11 Mar 2022 Class A Common Stock 500,000 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F2 The reporting person was previously granted awards of restricted stock units covering Class B Common Stock, which vest based upon the Issuer's achievement of an event condition (i.e., an underwritten initial public offering or a change in control), subject to additional time based vesting conditions in accordance with the terms of the award. On March 10, 2022, the Compensation Committee of the Issuer's Board of Directors, after consideration of the completion of the initial business combination, modified the event condition, resulting in the immediate vesting of 650,295 restricted stock units for which the time based vesting requirements had been satisfied as of December 31, 2021 and the issuance of a corresponding number of shares of Class B Common Stock. The remaining restricted stock units covering shares of Class B Common Stock will continue to vest in accordance with the terms of the award.
F3 Represents shares withheld by the Issuer to satisfy the reporting person's tax withholding obligations. Not a market sale.
F4 Represents an award of restricted stock units covering Class B Common Stock, which vests in 48 equal monthly installments following the vesting commencement date of March 1, 2022.
F5 Includes 40,000 restricted stock units covering Class B Common Stock that were previously reported as Restricted Stock Units on the Form 4 filed by the reporting person on January 26, 2022. The reporting person intends to report such restricted stock units on a consolidated basis with his holdings of the underlying Class B Common Stock in future reports.

Remarks:

Chief Financial Officer